Financials United-Guardian, Inc.

Equities

UG

US9105711082

Pharmaceuticals

Market Closed - Nasdaq 04:30:00 2024-04-26 pm EDT 5-day change 1st Jan Change
8.27 USD -1.24% Intraday chart for United-Guardian, Inc. +3.25% +14.86%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 84.26 90.28 66.06 75.58 47.96 33.08
Enterprise Value (EV) 1 76.09 82.36 57.87 67.41 41.48 23.98
P/E ratio 19.4 x 19 x 20 x 16.2 x 18.7 x 12.8 x
Yield 5.73% 5.6% 5.42% 6.87% 6.51% 4.86%
Capitalization / Revenue 6.12 x 6.64 x 6.01 x 5.43 x 3.78 x 3.04 x
EV / Revenue 5.53 x 6.06 x 5.27 x 4.84 x 3.27 x 2.2 x
EV / EBITDA 13.2 x 14.8 x 15.2 x 11.6 x 9.94 x 8.08 x
EV / FCF 22.1 x 25.2 x 19 x 16.3 x 26.8 x 10.8 x
FCF Yield 4.52% 3.98% 5.28% 6.14% 3.74% 9.25%
Price to Book 7.71 x 8.49 x 6.38 x 7.7 x 5.18 x 2.9 x
Nbr of stocks (in thousands) 4,594 4,594 4,594 4,594 4,594 4,594
Reference price 2 18.34 19.65 14.38 16.45 10.44 7.200
Announcement Date 3/21/19 3/26/20 3/22/21 3/23/22 3/23/23 3/22/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 13.77 13.6 10.99 13.93 12.7 10.89
EBITDA 1 5.772 5.572 3.801 5.813 4.173 2.969
EBIT 1 5.58 5.396 3.636 5.667 4.037 2.863
Operating Margin 40.52% 39.68% 33.1% 40.68% 31.79% 26.3%
Earnings before Tax (EBT) 1 5.466 6.03 4.161 5.878 3.228 3.251
Net income 1 4.352 4.762 3.305 4.659 2.57 2.581
Net margin 31.61% 35.01% 30.08% 33.44% 20.23% 23.71%
EPS 2 0.9473 1.036 0.7194 1.014 0.5593 0.5619
Free Cash Flow 1 3.438 3.275 3.053 4.142 1.549 2.218
FCF margin 24.97% 24.08% 27.79% 29.74% 12.2% 20.38%
FCF Conversion (EBITDA) 59.56% 58.77% 80.32% 71.25% 37.13% 74.72%
FCF Conversion (Net income) 78.98% 68.77% 92.39% 88.91% 60.3% 85.94%
Dividend per Share 2 1.050 1.100 0.7800 1.130 0.6800 0.3500
Announcement Date 3/21/19 3/26/20 3/22/21 3/23/22 3/23/23 3/22/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 8.17 7.92 8.18 8.17 6.48 9.09
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 3.44 3.27 3.05 4.14 1.55 2.22
ROE (net income / shareholders' equity) 39% 44.2% 31.5% 46.2% 26.9% 25%
ROA (Net income/ Total Assets) 27.5% 27.1% 18.7% 29.3% 22.1% 15.2%
Assets 1 15.85 17.58 17.66 15.89 11.65 17
Book Value Per Share 2 2.380 2.310 2.250 2.140 2.020 2.480
Cash Flow per Share 2 0.1200 0.2300 0.1300 0.1200 0.1800 1.790
Capex 1 0.07 0.11 0.04 0.12 0.08 0.17
Capex / Sales 0.54% 0.84% 0.39% 0.84% 0.59% 1.52%
Announcement Date 3/21/19 3/26/20 3/22/21 3/23/22 3/23/23 3/22/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. UG Stock
  4. Financials United-Guardian, Inc.